Summary

Persistence Market Research has recently published an in-depth report on the global Real-Time PCR (qPCR) market. This report provides a comprehensive evaluation of critical market dynamics, including drivers, trends, opportunities, and challenges, offering detailed insights into the market structure.

Key Insights:

• Real-Time PCR (qPCR) Market Size (2024E): USD 3.98 Billion
• Projected Market Value (2033F): USD 7.8 Billion
• Global Market Growth Rate (CAGR 2024 to 2033): 7.7%

Real-Time PCR (qPCR) Market - Report Scope:

Real-Time PCR (qPCR) technology is essential in various scientific applications, such as gene expression analysis, genetic variation studies, and pathogen detection. This technology allows for accurate and quantitative measurement of nucleic acids in real time, offering high sensitivity, specificity, and efficiency. The Real-Time PCR (qPCR) market serves research institutions, diagnostic laboratories, hospitals, and biotechnology companies, providing a range of instruments, reagents, and consumables.

Market Growth Drivers:

The global Real-Time PCR (qPCR) market is propelled by several factors, including the rising prevalence of infectious diseases and genetic disorders, which demand precise diagnostic tools. The increasing need for personalized medicine and advancements in molecular biology research further fuel market growth. Innovations in technology, such as the development of multiplex qPCR assays and enhancements in thermal cyclers, expand the capabilities and applications of Real-Time PCR. Additionally, growing research activities and funding in genomics and proteomics research contribute to the increased adoption of qPCR technology across various sectors.

Market Restraints:

Despite its promising growth, the Real-Time PCR (qPCR) market faces challenges related to the high costs of advanced instruments and reagents. The complexity of qPCR technology and the need for specialized training can also hinder adoption, especially in developing regions. Furthermore, stringent regulatory requirements for diagnostic assays and the need for continuous validation and calibration of instruments may impact market dynamics. Addressing these challenges necessitates ongoing innovation, cost-reduction strategies, and enhanced support for training and education.

Market Opportunities:

The Real-Time PCR (qPCR) market offers significant growth opportunities driven by technological advancements, expanding research and diagnostic applications, and increasing healthcare needs. The integration of qPCR with other molecular techniques, such as next-generation sequencing (NGS), opens new avenues for research and clinical diagnostics. The growing focus on infectious disease outbreaks and cancer diagnostics presents substantial opportunities for market players to develop innovative solutions. Strategic partnerships, investments in R&D, and the introduction of cost-effective qPCR solutions are crucial for capitalizing on emerging opportunities and maintaining market leadership.

Key Questions Answered in the Report:

• What are the primary factors driving the global Real-Time PCR (qPCR) market growth?
• Which qPCR technologies and applications are gaining traction in research and clinical settings?
• How are technological advancements influencing the competitive landscape of the Real-Time PCR (qPCR) market?
• Who are the key players in the Real-Time PCR (qPCR) market, and what strategies are they employing to stay relevant?
• What are the emerging trends and future prospects in the global Real-Time PCR (qPCR) market?

Competitive Intelligence and Business Strategy:

Leading companies in the global Real-Time PCR (qPCR) market, such as Thermo Fisher Scientific, Bio-Rad Laboratories, and Roche Diagnostics, emphasize innovation, product differentiation, and strategic collaborations to maintain a competitive edge. These firms invest in R&D to develop advanced qPCR platforms, reagents, and consumables tailored to diverse research and diagnostic needs. Collaborations with academic institutions, research organizations, and healthcare providers enhance market access and promote technology adoption. A focus on product development, regulatory compliance, and customer support drives market growth and strengthens competitive positioning in the rapidly evolving Real-Time PCR landscape.

Key Companies Profiled:

• Medtronic plc
• St. Jude Medical Inc.
• Boston Scientific Corporation
• Abbott
• Cyberonic, Inc.
• Qiagen
• Bio-Rad Laboratories Inc.
• Agilent Technologies, Inc.
• Thermo Fisher Scientific, Inc.
• GE Healthcare
• BIOMÉRIEUX
• Bio-Rad Laboratories, Inc.
• F. Hoffmann-La Roche Ltd.
• Fluidigm Corporation

Key Segments Covered in Real time PCR qPCR Industry Research

Product:
• Real-Time PCR (qPCR) Systems
• Reagents and Assays
• Real-Time PCR (qPCR) Consumables

Application:
• Clinical
• Research
• Forensic and Others

End User:
• Hospitals
• Diagnostic Laboratories
• Academic and Research Institutes
• Biopharmaceutical Companies
• Contract Research Organizations
• Animal Health
• Food & Agriculture Industries

Region:
• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East and Africa

ページTOPに戻る

Table of Contents

1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Technology Roadmap
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
4. Key Success Factors
4.1. Adoption Rate/Usage Analysis - By Region
4.2. Pipeline Assessment
4.3. Regulatory Scenario
4.4. Technology Assessment
4.5. PESTEL Analysis
4.6. Porter’s Analysis
4.7. Value Chain Analysis
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP Growth Outlook
5.1.2. Global Healthcare Outlook
5.1.3. Global Polymerase Chain Reaction Market Outlook
5.2. Forecast Factors - Relevance & Impact
5.2.1. Prevalence of Chronic and Infectious Diseases
5.2.2. Rising Adoption of Scientific Sciences
5.2.3. Growing Use of PCR Techniques
5.2.4. Expanding Biopharmaceutical and Biotechnology Industries
5.2.5. Increased Disease Diagnosis
5.2.6. Efforts in Discovering Novel Drugs
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. COVID-19 Crisis Analysis
6.1. COVID-19 and Impact Analysis
6.1.1. By Product
6.1.2. By Application
6.1.3. By End User
6.1.4. By Region
6.2. 2024 Market Scenario
7. Global Market Demand (in Value US$ Bn) Analysis 2019-2023 and Forecast, 2024-2033
7.1. Historical Market Value (US$ Bn) Analysis, 2019-2023
7.2. Current and Future Market Value (US$ Bn) Analysis and Forecast, 2024-2033
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Product
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Bn) Analysis, by Product, 2019-2023
8.3. Current and Future Market Size (US$ Bn) Analysis and Forecast, by Product, 2024-2033
8.3.1. Real-Time PCR (qPCR) Systems
8.3.2. Reagents and Assays
8.3.3. Real-Time PCR (qPCR) Consumables
8.3.3.1. PCR Primers, Assays, and Arrays
8.3.3.2. PCR Plates, Seals & Tubes
8.4. Market Attractiveness Analysis, by Product
9. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Application
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Bn) Analysis, By Application, 2019-2023
9.3. Current and Future Market Size (US$ Bn) Analysis and Forecast, by Application, 2024-2033
9.3.1. Clinical
9.3.2. Research
9.3.3. Forensic and Others
9.4. Market Attractiveness Analysis, by Application
10. Global Market Analysis 2019-2023 and Forecast 2024-2033, By End User
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Bn) Analysis, By End User, 2019-2023
10.3. Current and Future Market Size (US$ Bn) Analysis and Forecast, by End User, 2024-2033
10.3.1. Hospitals
10.3.2. Diagnostic Laboratories
10.3.3. Academic and Research Institutes
10.3.4. Biopharmaceutical Companies
10.3.5. Contract Research Organizations
10.3.6. Animal Health
10.3.7. Food & Agriculture Industries
10.4. Market Attractiveness Analysis, by End User
11. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Region
11.1. Introduction
11.2. Historical Market Size (US$ Bn) Analysis, by Region, 2019-2023
11.3. Current and Future Market Size (US$ Bn) Analysis and Forecast, by Region, 2024-2033
11.3.1. North America
11.3.2. Latin America
11.3.3. Europe
11.3.4. East Asia
11.3.5. South Asia
11.3.6. Oceania
11.3.7. Middle East and Africa (MEA)
11.4. Market Attractiveness Analysis, by Region
12. North America Market Analysis 2019-2023 and Forecast 2024-2033
12.1. Introduction
12.2. Historical Market Size (US$ Bn) Trend Analysis, by Market Taxonomy, 2019-2023
12.3. Current and Future Market Value (US$ Bn) Analysis and Forecast, by Market Taxonomy, 2024-2033
12.3.1. By Country
12.3.1.1. U.S.
12.3.1.2. Canada
12.3.2. By Product
12.3.3. By Application
12.3.4. By End User
12.4. Market Attractiveness Analysis
12.4.1. By Country
12.4.2. By Product
12.4.3. By Application
12.4.4. By End User
12.5. Market Trends
12.6. Key Market Participants - Intensity Mapping
12.7. Drivers and Restraints - Impact Analysis
12.8. Country Level Analysis & Forecast
12.8.1. U.S. Market Analysis
12.8.1.1. Introduction
12.8.1.2. Market Analysis and Forecast, by Market Taxonomy
12.8.1.2.1. By Product
12.8.1.2.2. By Application
12.8.1.2.3. By End User
12.8.2. Canada Market Analysis
12.8.2.1. Introduction
12.8.2.2. Market Analysis and Forecast, by Market Taxonomy
12.8.2.2.1. By Product
12.8.2.2.2. By Application
12.8.2.2.3. By End User
13. Latin America Market Analysis 2019-2023 and Forecast 2024-2033
13.1. Introduction
13.2. Historical Market Size (US$ Bn) Trend Analysis, by Market Taxonomy, 2019-2023
13.3. Current and Future Market Value (US$ Bn) Analysis and Forecast, by Market Taxonomy, 2024-2033
13.3.1. By Country
13.3.1.1. Mexico
13.3.1.2. Brazil
13.3.1.3. Argentina
13.3.1.4. Rest of Latin America
13.3.2. By Product
13.3.3. By Application
13.3.4. By End User
13.4. Market Attractiveness Analysis
13.4.1. By Country
13.4.2. By Product
13.4.3. By Application
13.4.4. By End User
13.5. Market Trends
13.6. Key Market Participants - Intensity Mapping
13.7. Drivers and Restraints - Impact Analysis
13.8. Country Level Analysis & Forecast
13.8.1. Mexico Market Analysis
13.8.1.1. Introduction
13.8.1.2. Market Analysis and Forecast, by Market Taxonomy
13.8.1.2.1. By Product
13.8.1.2.2. By Application
13.8.1.2.3. By End User
13.8.2. Brazil Market Analysis
13.8.2.1. Introduction
13.8.2.2. Market Analysis and Forecast, by Market Taxonomy
13.8.2.2.1. By Product
13.8.2.2.2. By Application
13.8.2.2.3. By End User
13.8.3. Argentina Market Analysis
13.8.3.1. Introduction
13.8.3.2. Market Analysis and Forecast, by Market Taxonomy
13.8.3.2.1. By Product
13.8.3.2.2. By Application
13.8.3.2.3. By End User
14. Europe Market Analysis 2019-2023 and Forecast 2024-2033
14.1. Introduction
14.2. Historical Market Size (US$ Bn) Trend Analysis, by Market Taxonomy, 2019-2023
14.3. Current and Future Market Value (US$ Bn) Analysis and Forecast, by Market Taxonomy, 2024-2033
14.3.1. By Country
14.3.1.1. Germany
14.3.1.2. Italy
14.3.1.3. France
14.3.1.4. U.K.
14.3.1.5. Spain
14.3.1.6. BENELUX
14.3.1.7. Russia
14.3.1.8. Rest of Europe
14.3.2. By Product
14.3.3. By Application
14.3.4. By End User
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Product
14.4.3. By Application
14.4.4. By End User
14.5. Market Trends
14.6. Key Market Participants - Intensity Mapping
14.7. Drivers and Restraints - Impact Analysis
14.8. Country Level Analysis & Forecast
14.8.1. Germany Market Analysis
14.8.1.1. Introduction
14.8.1.2. Market Analysis and Forecast, by Market Taxonomy
14.8.1.2.1. By Product
14.8.1.2.2. By Application
14.8.1.2.3. By End User
14.8.2. Italy Market Analysis
14.8.2.1. Introduction
14.8.2.2. Market Analysis and Forecast, by Market Taxonomy
14.8.2.2.1. By Product
14.8.2.2.2. By Application
14.8.2.2.3. By End User
14.8.3. France Market Analysis
14.8.3.1. Introduction
14.8.3.2. Market Analysis and Forecast, by Market Taxonomy
14.8.3.2.1. By Product
14.8.3.2.2. By Application
14.8.3.2.3. By End User
14.8.4. U.K. Market Analysis
14.8.4.1. Introduction
14.8.4.2. Market Analysis and Forecast, by Market Taxonomy
14.8.4.2.1. By Product
14.8.4.2.2. By Application
14.8.4.2.3. By End User
14.8.5. Spain Market Analysis
14.8.5.1. Introduction
14.8.5.2. Market Analysis and Forecast, by Market Taxonomy
14.8.5.2.1. By Product
14.8.5.2.2. By Application
14.8.5.2.3. By End User
14.8.6. BENELUX Market Analysis
14.8.6.1. Introduction
14.8.6.2. Market Analysis and Forecast, by Market Taxonomy
14.8.6.2.1. By Product
14.8.6.2.2. By Application
14.8.6.2.3. By End User
14.8.7. Russia Market Analysis
14.8.7.1. Introduction
14.8.7.2. Market Analysis and Forecast, by Market Taxonomy
14.8.7.2.1. By Product
14.8.7.2.2. By Application
14.8.7.2.3. By End User
15. East Asia Market Analysis 2019-2023 and Forecast 2024-2033
15.1. Introduction
15.2. Historical Market Size (US$ Bn) Trend Analysis, by Market Taxonomy, 2019-2023
15.3. Current and Future Market Value (US$ Bn) Analysis and Forecast, by Market Taxonomy, 2024-2033
15.3.1. By Country
15.3.1.1. China
15.3.1.2. Japan
15.3.1.3. South Korea
15.3.2. By Product
15.3.3. By Application
15.3.4. By End User
15.4. Market Attractiveness Analysis
15.4.1. By Product
15.4.2. By Application
15.4.3. By End User
15.5. Market Trends
15.6. Key Market Participants - Intensity Mapping
15.7. Drivers and Restraints - Impact Analysis
15.8. Country Level Analysis & Forecast
15.8.1. China Market Analysis
15.8.1.1. Introduction
15.8.1.2. Market Analysis and Forecast, by Market Taxonomy
15.8.1.2.1. By Product
15.8.1.2.2. By Application
15.8.1.2.3. By End User
15.8.2. Japan Market Analysis
15.8.2.1. Introduction
15.8.2.2. Market Analysis and Forecast, by Market Taxonomy
15.8.2.2.1. By Product
15.8.2.2.2. By Application
15.8.2.2.3. By End User
15.8.3. South Korea Market Analysis
15.8.3.1. Introduction
15.8.3.2. Market Analysis and Forecast, by Market Taxonomy
15.8.3.2.1. By Product
15.8.3.2.2. By Application
15.8.3.2.3. By End User
16. South Asia Market Analysis 2019-2023 and Forecast 2024-2033
16.1. Introduction
16.2. Historical Market Size (US$ Bn) Trend Analysis, by Market Taxonomy, 2019-2023
16.3. Current and Future Market Value (US$ Bn) Analysis and Forecast, by Market Taxonomy, 2024-2033
16.3.1. By Country
16.3.1.1. India
16.3.1.2. Indonesia
16.3.1.3. Malaysia
16.3.1.4. Thailand
16.3.1.5. Rest of South Asia
16.3.2. By Product
16.3.3. By Application
16.3.4. By End User
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Product
16.4.3. By Application
16.4.4. By End User
16.5. Market Trends
16.6. Key Market Participants - Intensity Mapping
16.7. Drivers and Restraints - Impact Analysis
16.8. Country Level Analysis & Forecast
16.8.1. India Market Analysis
16.8.1.1. Introduction
16.8.1.2. Market Analysis and Forecast, by Market Taxonomy
16.8.1.2.1. By Product
16.8.1.2.2. By Application
16.8.1.2.3. By End User
16.8.2. Indonesia Market Analysis
16.8.2.1. Introduction
16.8.2.2. Market Analysis and Forecast, by Market Taxonomy
16.8.2.2.1. By Product
16.8.2.2.2. By Application
16.8.2.2.3. By End User
16.8.3. Malaysia Market Analysis
16.8.3.1. Introduction
16.8.3.2. Market Analysis and Forecast, by Market Taxonomy
16.8.3.2.1. By Product
16.8.3.2.2. By Application
16.8.3.2.3. By End User
16.8.4. Thailand Market Analysis
16.8.4.1. Introduction
16.8.4.2. Market Analysis and Forecast, by Market Taxonomy
16.8.4.2.1. By Product
16.8.4.2.2. By Application
16.8.4.2.3. By End User
17. Oceania Market 2019-2023 and Forecast 2024-2033
17.1. Introduction
17.2. Historical Market Size (US$ Bn) Trend Analysis, by Market Taxonomy, 2019-2023
17.3. Current and Future Market Value (US$ Bn) Analysis and Forecast, by Market Taxonomy, 2024-2033
17.3.1. By Country
17.3.1.1. Australia
17.3.1.2. New Zealand
17.3.2. By Product
17.3.3. By Application
17.3.4. By End User
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Product
17.4.3. By Application
17.4.4. By End User
17.5. Market Trends
17.6. Key Market Participants - Intensity Mapping
17.7. Drivers and Restraints - Impact Analysis
17.8. Country Level Analysis & Forecast
17.8.1. Australia Market Analysis
17.8.1.1. Introduction
17.8.1.2. Market Analysis and Forecast, by Market Taxonomy
17.8.1.2.1. By Product
17.8.1.2.2. By Application
17.8.1.2.3. By End User
17.8.2. New Zealand Market Analysis
17.8.2.1. Introduction
17.8.2.2. Market Analysis and Forecast, by Market Taxonomy
17.8.2.2.1. By Product
17.8.2.2.2. By Application
17.8.2.2.3. By End User
18. Middle East and Africa (MEA) Market Analysis 2019-2023 and Forecast 2024-2033
18.1. Introduction
18.2. Historical Market Size (US$ Bn) Trend Analysis, by Market Taxonomy, 2019-2023
18.3. Current and Future Market Value (US$ Bn) Analysis and Forecast, by Market Taxonomy, 2024-2033
18.3.1. By Country
18.3.1.1. GCC Countries
18.3.1.2. Türkiye
18.3.1.3. South Africa
18.3.1.4. North Africa
18.3.1.5. Rest of Middle East and Africa
18.3.2. By Product
18.3.3. By Application
18.3.4. By End User
18.4. Market Attractiveness Analysis
18.4.1. By Product
18.4.2. By Application
18.4.3. By End User
18.5. Market Trends
18.6. Key Market Participants - Intensity Mapping
18.7. Drivers and Restraints - Impact Analysis
18.8. Country Level Analysis & Forecast
18.8.1. GCC Countries Market Analysis
18.8.1.1. Introduction
18.8.1.2. Market Analysis and Forecast, by Market Taxonomy
18.8.1.2.1. By Product
18.8.1.2.2. By Application
18.8.1.2.3. By End User
18.8.2. Türkiye Market Analysis
18.8.2.1. Introduction
18.8.2.2. Market Analysis and Forecast, by Market Taxonomy
18.8.2.2.1. By Product
18.8.2.2.2. By Application
18.8.2.2.3. By End User
18.8.3. South Africa Market Analysis
18.8.3.1. Introduction
18.8.3.2. Market Analysis and Forecast, by Market Taxonomy
18.8.3.2.1. By Product
18.8.3.2.2. By Application
18.8.3.2.3. By End User
18.8.4. North Africa Market Analysis
18.8.4.1. Introduction
18.8.4.2. Market Analysis and Forecast, by Market Taxonomy
18.8.4.2.1. By Product
18.8.4.2.2. By Application
18.8.4.2.3. By End User
19. Market Structure Analysis
19.1. Market Analysis, by Tier of Companies
19.2. Market Share Analysis of Top Players
19.3. Market Presence Analysis
20. Competition Analysis
20.1. Competition Dashboard
20.2. Competition Benchmarking
20.3. Competition Deep Dive
20.3.1. Medtronic plc
20.3.1.1. Overview
20.3.1.2. Product Portfolio
20.3.1.3. Sales Footprint
20.3.1.4. Key Financials
20.3.1.5. SWOT Analysis
20.3.1.6. Strategy Overview
20.3.1.6.1. Marketing Strategy
20.3.1.6.2. Product Strategy
20.3.1.6.3. Channel Strategy
20.3.2. St. Jude Medical Inc.
20.3.2.1. Overview
20.3.2.2. Product Portfolio
20.3.2.3. Sales Footprint
20.3.2.4. Key Financials
20.3.2.5. SWOT Analysis
20.3.2.6. Strategy Overview
20.3.2.6.1. Marketing Strategy
20.3.2.6.2. Product Strategy
20.3.2.6.3. Channel Strategy
20.3.3. Boston Scientific Corporation
20.3.3.1. Overview
20.3.3.2. Product Portfolio
20.3.3.3. Sales Footprint
20.3.3.4. Key Financials
20.3.3.5. SWOT Analysis
20.3.3.6. Strategy Overview
20.3.3.6.1. Marketing Strategy
20.3.3.6.2. Product Strategy
20.3.3.6.3. Channel Strategy
20.3.4. Abbott
20.3.4.1. Overview
20.3.4.2. Product Portfolio
20.3.4.3. Sales Footprint
20.3.4.4. Key Financials
20.3.4.5. SWOT Analysis
20.3.4.6. Strategy Overview
20.3.4.6.1. Marketing Strategy
20.3.4.6.2. Product Strategy
20.3.4.6.3. Channel Strategy
20.3.5. Cyberonic, Inc.
20.3.5.1. Overview
20.3.5.2. Product Portfolio
20.3.5.3. Sales Footprint
20.3.5.4. Key Financials
20.3.5.5. SWOT Analysis
20.3.5.6. Strategy Overview
20.3.5.6.1. Marketing Strategy
20.3.5.6.2. Product Strategy
20.3.5.6.3. Channel Strategy
20.3.6. Qiagen
20.3.6.1. Overview
20.3.6.2. Product Portfolio
20.3.6.3. Sales Footprint
20.3.6.4. Key Financials
20.3.6.5. SWOT Analysis
20.3.6.6. Strategy Overview
20.3.6.6.1. Marketing Strategy
20.3.6.6.2. Product Strategy
20.3.6.6.3. Channel Strategy
20.3.7. Bio-Rad Laboratories Inc.
20.3.7.1. Overview
20.3.7.2. Product Portfolio
20.3.7.3. Sales Footprint
20.3.7.4. Key Financials
20.3.7.5. SWOT Analysis
20.3.7.6. Strategy Overview
20.3.7.6.1. Marketing Strategy
20.3.7.6.2. Product Strategy
20.3.7.6.3. Channel Strategy
20.3.8. Agilent Technologies, Inc.
20.3.8.1. Overview
20.3.8.2. Product Portfolio
20.3.8.3. Sales Footprint
20.3.8.4. Key Financials
20.3.8.5. SWOT Analysis
20.3.8.6. Strategy Overview
20.3.8.6.1. Marketing Strategy
20.3.8.6.2. Product Strategy
20.3.8.6.3. Channel Strategy
20.3.9. Thermo Fisher Scientific, Inc.
20.3.9.1. Overview
20.3.9.2. Product Portfolio
20.3.9.3. Sales Footprint
20.3.9.4. Key Financials
20.3.9.5. SWOT Analysis
20.3.9.6. Strategy Overview
20.3.9.6.1. Marketing Strategy
20.3.9.6.2. Product Strategy
20.3.9.6.3. Channel Strategy
20.3.10. GE Healthcare
20.3.10.1. Overview
20.3.10.2. Product Portfolio
20.3.10.3. Sales Footprint
20.3.10.4. Key Financials
20.3.10.5. SWOT Analysis
20.3.10.6. Strategy Overview
20.3.10.6.1. Marketing Strategy
20.3.10.6.2. Product Strategy
20.3.10.6.3. Channel Strategy
20.3.11. BIOMÉRIEUX
20.3.11.1. Overview
20.3.11.2. Product Portfolio
20.3.11.3. Sales Footprint
20.3.11.4. Key Financials
20.3.11.5. SWOT Analysis
20.3.11.6. Strategy Overview
20.3.11.6.1. Marketing Strategy
20.3.11.6.2. Product Strategy
20.3.11.6.3. Channel Strategy
20.3.12. Bio-Rad Laboratories, Inc.
20.3.12.1. Overview
20.3.12.2. Product Portfolio
20.3.12.3. Sales Footprint
20.3.12.4. Key Financials
20.3.12.5. SWOT Analysis
20.3.12.6. Strategy Overview
20.3.12.6.1. Marketing Strategy
20.3.12.6.2. Product Strategy
20.3.12.6.3. Channel Strategy
20.3.13. F. Hoffmann-La Roche Ltd.
20.3.13.1. Overview
20.3.13.2. Product Portfolio
20.3.13.3. Sales Footprint
20.3.13.4. Key Financials
20.3.13.5. SWOT Analysis
20.3.13.6. Strategy Overview
20.3.13.6.1. Marketing Strategy
20.3.13.6.2. Product Strategy
20.3.13.6.3. Channel Strategy
20.3.14. Fluidigm Corporation
20.3.14.1. Overview
20.3.14.2. Product Portfolio
20.3.14.3. Sales Footprint
20.3.14.4. Key Financials
20.3.14.5. SWOT Analysis
20.3.14.6. Strategy Overview
20.3.14.6.1. Marketing Strategy
20.3.14.6.2. Product Strategy
20.3.14.6.3. Channel Strategy
21. Assumptions and Acronyms Used
22. Research Methodology